tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

INKT Stock Latest News

Why Is MiNK Therapeutics Stock (INKT) Up 190% Today?
Market NewsWhy Is MiNK Therapeutics Stock (INKT) Up 190% Today?
9h ago
INKT
MiNK Therapeutics downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
MiNK Therapeutics downgraded to Market Perform from Outperform at William Blair
12h ago
INKT
MiNK data published showing complete remission, says H.C. Wainwright
PremiumThe Fly
MiNK data published showing complete remission, says H.C. Wainwright
19h ago
INKT
Promising Clinical Results and Positive Outlook for MiNK Therapeutics’ agenT-797 Drive Buy Rating
PremiumRatings
Promising Clinical Results and Positive Outlook for MiNK Therapeutics’ agenT-797 Drive Buy Rating
19h ago
INKT
Mink Therapeutics Inc trading resumes
PremiumThe Fly
Mink Therapeutics Inc trading resumes
20h ago
INKT
Mink Therapeutics Inc trading halted, volatility trading pause
PremiumThe FlyMink Therapeutics Inc trading halted, volatility trading pause
20h ago
INKT
MiNK Therapeutics announces publication of complete remission using agenT-797
Premium
The Fly
MiNK Therapeutics announces publication of complete remission using agenT-797
22h ago
INKT
MiNK Therapeutics Holds Annual Stockholders Meeting
Premium
Company Announcements
MiNK Therapeutics Holds Annual Stockholders Meeting
24d ago
8K
INKT
MiNK Therapeutics awarded NIAID grant to advance Allo-iNKT cell therapy
PremiumThe Fly
MiNK Therapeutics awarded NIAID grant to advance Allo-iNKT cell therapy
1M ago
INKT
MiNK Therapeutics Reports Q1 2025 Progress and Financials
PremiumCompany Announcements
MiNK Therapeutics Reports Q1 2025 Progress and Financials
2M ago
INKT
Mink Therapeutics’ Earnings Call Highlights Progress and Optimism
PremiumCompany Announcements
Mink Therapeutics’ Earnings Call Highlights Progress and Optimism
2M ago
INKT
Positive Outlook for MiNK Therapeutics: Promising Clinical Developments and Financial Performance
PremiumRatings
Positive Outlook for MiNK Therapeutics: Promising Clinical Developments and Financial Performance
2M ago
INKT
MiNK Therapeutics: Promising Clinical Trials and Strategic Plans Justify Buy Rating
PremiumRatingsMiNK Therapeutics: Promising Clinical Trials and Strategic Plans Justify Buy Rating
2M ago
INKT
MiNK Therapeutics reports Q1 EPS (70c) vs ($1.10) last year
Premium
The Fly
MiNK Therapeutics reports Q1 EPS (70c) vs ($1.10) last year
2M ago
INKT
INKT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INKT Upcoming Earnings Report: What to Expect?
2M ago
INKT
MiNK Therapeutics Reports 2024 Progress and Financials
PremiumCompany Announcements
MiNK Therapeutics Reports 2024 Progress and Financials
4M ago
INKT
MiNK Therapeutics’ Earnings Call Highlights Strategic Gains
PremiumCompany Announcements
MiNK Therapeutics’ Earnings Call Highlights Strategic Gains
4M ago
INKT
Buy Rating Affirmed for MiNK Therapeutics Amid Promising Clinical Developments and Strategic Expansion
PremiumRatings
Buy Rating Affirmed for MiNK Therapeutics Amid Promising Clinical Developments and Strategic Expansion
4M ago
INKT
Promising Clinical Data and Strategic Initiatives Drive Buy Rating for MiNK Therapeutics
PremiumRatings
Promising Clinical Data and Strategic Initiatives Drive Buy Rating for MiNK Therapeutics
4M ago
INKT
Morning Movers: Sarepta slumps after death following Elevidys use
PremiumThe FlyMorning Movers: Sarepta slumps after death following Elevidys use
4M ago
BTM
BTU
MiNK Therapeutics reports Q4 EPS (62c), consensus (50c)
Premium
The Fly
MiNK Therapeutics reports Q4 EPS (62c), consensus (50c)
4M ago
INKT
Mink Therapeutics, Inc. (INKT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Mink Therapeutics, Inc. (INKT) Q4 Earnings Cheat Sheet
4M ago
INKT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >